Red-cell IgM-antibody capture assay for the detection of Mycoplasma pneumoniae-specific IgM

A red-cell IgM-antibody capture assay has been developed for detecting Mycoplasma pneumoniae-specific IgM, which is based on the adsorption or ‘capture’ of IgM from patients' sera onto so-called ‘inagglutinable’ bovine red cells, chemically linked with anti-human μ When M. pneumoniae antigen is...

Full description

Saved in:
Bibliographic Details
Published in:Epidemiology and infection Vol. 100; no. 1; pp. 101 - 109
Main Authors: Coombs, R. R. A., Easter, Gwen, Matejtschuk, P., Wreghitt, T. G.
Format: Journal Article
Language:English
Published: Cambridge, UK Cambridge University Press 01-02-1988
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A red-cell IgM-antibody capture assay has been developed for detecting Mycoplasma pneumoniae-specific IgM, which is based on the adsorption or ‘capture’ of IgM from patients' sera onto so-called ‘inagglutinable’ bovine red cells, chemically linked with anti-human μ When M. pneumoniae antigen is added to the system, the red cells agglutinate in the presence of M. pneumoniae-specific IgM. The test was compared with the μ-capture ELISA described by Wreghitt & Sillis (1985), and was found to give comparable results. The two tests had similar sensitivity and specificity and could detect M. pneumoniae-spcific IgM for a similar time (up to 6 months) after proven M. pneumoniae infection. However, the red-cell antibody capture assay is a much more simple and rapid test, taking only 1 h to perform (compared to 24 h for μ-capture ELISA). The redcell IgM-antibody capture assay is therefore amenable to rapid diagnosis of M. pneumoniae infection and the institution of early appropriate antibiotic therapy.
Bibliography:PII:S0950268800065602
ark:/67375/6GQ-VCH2VN3G-D
ArticleID:06560
istex:1167EA857A0C06A0EB98527D71E102ADFEDE84D5
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0950-2688
1469-4409
DOI:10.1017/S0950268800065602